The cross-reactivity of anti-asparaginase antibodies against different l-asparaginase preparations

Clinical and Experimental Medicine

Volumn 9, Issue 2, 2009, Pages 113-116

  Zalewska Szewczyk, Beata ^a   Gach, Agnieszka ^a   Wyka, Krystyna ^a   Bodalski, Jerzy ^a   Młynarski, Wojciech ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Acute lymphoblastic leukemia; Anti asparaginase antibodies; Cross reactivity; Hypersensitivity reactions

Indexed keywords

ASPARAGINASE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLERGIC REACTION; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CROSS REACTION; ENZYME ACTIVITY; ESCHERICHIA COLI; HUMAN; IMMUNOREACTIVITY; PECTOBACTERIUM CHRYSANTHEMI; PRIORITY JOURNAL;

ANTIBODIES; ASPARAGINASE; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; HUMANS; PECTOBACTERIUM CHRYSANTHEMI;

ERWINIA;

EID: 67349120973     PISSN: 15918890     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10238-008-0026-9     Document Type: Article

References (18)

1. UK Narta SS Kanwar W Azmi 2007 Pharmacological and clinical evaluation of l-asparaginase in the treatment of leukemia Crit Rev Oncol Hematol 61 208 221 (Pubitemid 46329425)
2. M Duval S Suciu A Ferster X Rialland B Nelken P Lutz Y Benoit A Robert AM Manel E Vilmer J Otten N Philippe 2002 Comparison of Echerichia coli-asparaginase with Erwinia-asparaginase in the treatment of acute lymphoblastic leukemia: results of a randomized European Organisation for Research and Treatment of Cancer-Children's Leukemia Group phase 3 trial Blood 99 2734 2739 (Pubitemid 34525359)
3. HJ Müller J Boos 1998 Use of l-asparaginase in childhood ALL Crit Rev Oncol Hematol 28 97 113 (Pubitemid 28390409)
4. CH Pui 1995 Childhood leukemia N Engl J Med 332 1618 1630
5. VI Avramis S Sencer AP Periclou H Sather BC Bostrom LJ Cohen AG Ettingrer LJ Ettinger J Franklin PS Gaynon JM Hilden B Lange F Majlessipour P Mathew M Needle J Neqlia G Reaman JS Holcenberg L Stork 2002 A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group Study Blood 99 1986 1994 (Pubitemid 34525479)
6. JD Broome 1968 Factors which may influence the effectiveness of l-asparaginase as tumor inhibitors Br J Cancer 22 595 602
7. A Abuchowski GM Kazo CR Verhoest Jr T Van Es D Kafkevitz ML Nuci AT Viau FF Davis 1984 Cancer therapy with chemically modified enzymes. I Antitumor properties of polyethylene glycol-asparaginase conjugates Cancer Biochem Biophys 7 175 186 (Pubitemid 14087243)
8. NK Cheung IY Chau PF Coccia 1986 Antibody response to Escherichia coli l-asparaginase: prognostic significance and clinical utility of antibody measurement Am J Pediatr Hematol Oncol 8 99 104 (Pubitemid 16092149)
9. MH Woo LJ Hak MC Storm WE Evans JT Sandlund GK Rivera P Wang CH Pui MV Relling 1998 Anti-asparaginase antibodies following E. coli asparaginase therapy in pediatric acute lymphoblastic leukemia Leukemia 12 1527 1533 (Pubitemid 28470435)
10. BL Asselin JC Whithin DJ Coppola IP Rupp SE Sallan HJ Cohen 1993 Comparative pharmacokinetic studies of three asparaginase preparation J Clin Oncol 11 1780 1786 (Pubitemid 23277332)
11. Y Kamisaki H Wada T Yagura A Matsushimi Y Inada 1981 Reduction in immunogenecity and clearence rate of Echerichia coli l-asparaginase by modification with monomethoxypolyethylene glycol J Pharmacol Exp Ther 216 410 414 (Pubitemid 11130205)
12. T Yashimoto H Nishimura Y Saito 1986 Characterization of PEG modified l-asparaginase from E. coli and its application to the therapy of leukemia Jpn J Cancer Res 77 1264 1271 (Pubitemid 17233904)
13. B Zalewska-Szewczyk W Andrzejewski J Bodalski 2004 Development of anti-asparaginase antibodies in childhood lymphoblastic leukemia Pediatr Blood Cancer 43 600 602 (Pubitemid 39313961)
14. LJ Ettinger J Kurtzberg PA Voute 1995 An open-label, multicenter study of polyethylene glycol l-asparaginase for the treatment of acute lymphoblastic leukemia Cancer 75 1176 1181
15. EH Panosyan NL Seibel S Martin-Aragon PS Gaynon IA Avramis H Sather J Franklin J Nachman LJ Ettinger P Steinherz LJ Cohen SE Siegel VI Avramis 2004 Children's Cancer Group StudyAsparaginase antibody and asparaginase activity in children with higher-risk acute lymphoblastic leukemia J Pediatr Hematol Oncol 26 217 226 (Pubitemid 38500969)
16. B Wang MV Relling MC Storm MH Woo R Ribeiro CH Pui LJ Hak 2003 Evaluation of immunologic crossreaction of antiasparaginase antibodies in acute lymphoblastic leukemia (ALL) and lymphoma patients Leukemia 17 1583 1588 (Pubitemid 36992159)
17. HJ Müller L Löning A Horn D Schwabe M Gunkel M Schrappe V von Schütz G Henze J Casimiro da Palma J Ritter JP Pinheiro M Winkelhorst J Boos 2000 Pegylated asparaginase (Oncaspar™) in children with ALL: drug monitoring in reinduction according to the ALL/NHL-BFM 95 protocols Br J Haematol 110 379 384 (Pubitemid 30646864)
18. BK Albertsen H Schrøder P Jakobsen VI Avramis HJ Muller K Schmiegelow NT Carlsen 2002 Antibody formation during intravenous and intramuscular therapy with Erwinia asparaginase Med Pediatr Oncol 38 310 316 (Pubitemid 34493110)